Rosecliff Acquisition Corp. I (NASDAQ:RCLF) announced in an 8-K this morning that its shareholders approved its combination with medtech firm Spectral MD (AIM:SMD) at a special meeting yesterday.
Although all proposals on the ballot were approved by wide margins, an additional 211,136 shares were redeemed in connection with the vote, reducing Rosecliff I’s trust to about $2.6 million with 247,580 public shares outstanding. This leaves Rosecliff I with a final redemption rate of 99% and it did not supplement its trust with additional outside funding.
The parties aimed to deliver proceeds of about $20 million at announcement, but the transaction did not carry a minimum cash condition. However, because this result would mean providing total proceeds under $10 million, Rosecliff I’s sponsor would be expected to reduce its promote shares holdings by -88% to 750,000 under the combination agreement.
Rosecliff I still has plenty of time under its transaction deadline to add funding mechanisms to the deal and this deal’s outside date is September 30. But, the SPAC notes in the filing that it expects to close the deal by September 11, after which the combined company’s shares are to uplist to the Nasdaq under the symbol “MDAI”.
The two sides also modified their 180-day lock-up agreement yesterday. Previously, company shareholders and Rosecliff I’s sponsor were set to have 33.33% of holdings released early if company stock were to trade at or above $12.50 for 20 of 30 trading days and another 50% at a similar $15 hurdle.
Under the changes, all shares are to be released early if the stock hits the $12.50 target for 10 of 30 trading days.
The two sides initially announced their $170 million combination on April 11. Dallas, Texas-based Spectral MD develops technology using predictive analytics and AI algorithms to help clinicians make more accurate and faster treatment decisions.
It reported generating $25.4 million in revenue in 2022 for an EBITDA loss of -$2.8 million. The company also received a $4 million grant from the Medical Technology Enterprise Consortium in April and received positive results in a peer-reviewed study of its DeepView wound care technology in June.
At the SPAC of Dawn SPAC activity has continued on hot and heavy as three more new SPACs have filed S-1s for IPOs – one from each of the year’s most prolific underwriters: Cantor Fitzgerald, BTIG and Cohen & Company. Two more SPACs have are also set to join the party today having priced their...
Republic Digital Acquisition Corp. (NASDAQ:RDAGU) announced the pricing of its upsized $264 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “RDAGU”, Thursday, May 1, 2025. The new SPAC aims to combine with a target company in the fintech, software or cryptocurrency industries with substantial free cash flow....
Copley Acquisition Corp. (NYSE:COPL.U) announced the pricing of its $150 million IPO and its units are expected to begin trading on the NYSE under the symbol “COPL.U”, Thursday, May 1, 2025. The new SPAC aims to combine with a company in the technology or lifestyle sectors that have the ability to scale and enhance growth....
Wintergreen Acquisition Corp. (NASDAQ:WTGU) has filed for a $50 million SPAC with a focus on technology and media firms in Asia and China specifically at a particularly interesting time. The new SPAC acknowledges in the second paragraph of its S-1 that this focus “may subject us to significantly elevated regulatory, liquidity, and enforcement risk”, which...
May is to extend a theme for the spring of 2025 with very few de-SPACs and sponsors coming free of their lock-up agreements. This is due in some cases to stellar performance but more broadly due to the slowdown in deal closings about 12 and six months ago. One way or the other, four sponsors...